Mereo BioPharma Financials
| 0A9G Stock | 3.72 0.10 2.76% |
Operating Margin (38.07) | Return On Equity (0.74) |
Mereo | Select Account or Indicator |
Understanding current and past Mereo BioPharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Mereo BioPharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Mereo BioPharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Mereo BioPharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mereo BioPharma Group. Check Mereo BioPharma's Beneish M Score to see the likelihood of Mereo BioPharma's management manipulating its earnings.
Mereo BioPharma Stock Summary
Mereo BioPharma competes with Samsung Electronics, Samsung Electronics, Hyundai, Toyota, and MOL Hungarian. Mereo BioPharma is entity of United Kingdom. It is traded as Stock on LSE exchange.Specialization | Industrials, Commercial & Professional Services |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| Business Address | One Cavendish Place, |
| Sector | Commercial Services & Supplies |
| Industry | Industrials |
| Benchmark | Dow Jones Industrial |
| Website | www.mereobiopharma.com |
| Phone | 44 33 3023 7300 |
You should never invest in Mereo BioPharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Mereo Stock, because this is throwing your money away. Analyzing the key information contained in Mereo BioPharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Mereo BioPharma Key Financial Ratios
There are many critical financial ratios that Mereo BioPharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Mereo BioPharma Group reports annually and quarterly.| Net Income | (34.2 M) | ||||
| Retained Earnings | (331.16 M) |
Mereo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mereo BioPharma's current stock value. Our valuation model uses many indicators to compare Mereo BioPharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mereo BioPharma competition to find correlations between indicators driving Mereo BioPharma's intrinsic value. More Info.Mereo BioPharma Group is rated below average in return on equity category among its peers. It is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mereo BioPharma's earnings, one of the primary drivers of an investment's value.Mereo BioPharma Group Systematic Risk
Mereo BioPharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mereo BioPharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Mereo BioPharma Group correlated with the market. If Beta is less than 0 Mereo BioPharma generally moves in the opposite direction as compared to the market. If Mereo BioPharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mereo BioPharma Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mereo BioPharma is generally in the same direction as the market. If Beta > 1 Mereo BioPharma moves generally in the same direction as, but more than the movement of the benchmark.
Mereo BioPharma Group Other Current Liab Over Time
Mereo BioPharma November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mereo BioPharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mereo BioPharma Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mereo BioPharma Group based on widely used predictive technical indicators. In general, we focus on analyzing Mereo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mereo BioPharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 17.99 | |||
| Value At Risk | (6.05) | |||
| Potential Upside | 5.4 |
Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.